Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44

Jae Seung Kang, Seyeon Y. Bae, Hangrae R. Kim, Yeong Seok Kim, Daejin J. Kim, Byung Joo Cho, Han Kwang Yang, Young Il Hwang, Kyungjae J. Kim, Hong Suk Park, Doukho H. Hwang, Dae Ho Cho, Wang Jae Lee

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Cancer cells metastasize to the other site after escaping from the immune system and CD70, CD44 and vascular endothelial growth factor (VEGF) play important roles in this process. It is recently reported that interleukin (IL)-18 is closely related with the pathogenesis of skin tumor. Therefore, we investigated the role of endogenous IL-18 from stomach cancer on the immune escape mechanism and metastasis via the regulation of CD70, CD44 and VEGF expression. IL-18 and IL-18R expressions were not only investigated on tumor tissues (n = 10), and sera (n = 20) from stomach cancer patients, but also on human stomach cancer cell lines. IL-18 and IL-18R expressions were found on stomach cancer cell lines and tumor tissues. In addition, IL-18 levels were elevated in sera from cancer patients (P < 0.05), compared with sera from normal individuals. Changes in CD70, CD44 and VEGF expression by flow cytometry, immunoblotting and enzyme-linked immunosorbent assay and immune susceptibility by . 51 Cr-release assay were investigated, after silencing or neutralization of endogenous IL-18. CD70 expression was increased and it increases immune susceptibility of cancer cells. In contrast, CD44 and VEGF expression was decreased and it suppresses neovascularization and the metastasis of stomach cancer. After inoculation of IL-18 small interfering RNA (siRNA)-transfected stomach cancer cells into Balb/C (nu/nu) mice, regression of tumor mass was determined by measuring of tumor size. And the number and location of metastatic lesions were investigated by hematoxylin and eosin staining. The regression of tumor mass and the suppression of metastasis were observed in the mice, which are injected with IL-18 siRNA-transfected cell lines. Our data suggest that endogenous IL-18 might facilitate stomach cancer cell immune escape by suppressing CD70 and increasing metastatic ability by upregulating CD44 and VEGF.

Original languageEnglish
Pages (from-to)1987-1996
Number of pages10
JournalCarcinogenesis
Volume30
Issue number12
DOIs
Publication statusPublished - 2009 Jul 28
Externally publishedYes

Fingerprint

Interleukin-18
Stomach Neoplasms
Down-Regulation
Maintenance
Neoplasm Metastasis
Vascular Endothelial Growth Factor A
Neoplasms
Interleukins
Small Interfering RNA
Serum
Cell Line
Hematoxylin
Eosine Yellowish-(YS)
Tumor Cell Line
Immunoblotting
Immune System
Flow Cytometry
Enzyme-Linked Immunosorbent Assay
Staining and Labeling
Skin

ASJC Scopus subject areas

  • Cancer Research

Cite this

Kang, J. S., Bae, S. Y., Kim, H. R., Kim, Y. S., Kim, D. J., Cho, B. J., ... Lee, W. J. (2009). Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. Carcinogenesis, 30(12), 1987-1996. https://doi.org/10.1093/carcin/bgp158

Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. / Kang, Jae Seung; Bae, Seyeon Y.; Kim, Hangrae R.; Kim, Yeong Seok; Kim, Daejin J.; Cho, Byung Joo; Yang, Han Kwang; Hwang, Young Il; Kim, Kyungjae J.; Park, Hong Suk; Hwang, Doukho H.; Cho, Dae Ho; Lee, Wang Jae.

In: Carcinogenesis, Vol. 30, No. 12, 28.07.2009, p. 1987-1996.

Research output: Contribution to journalArticle

Kang, JS, Bae, SY, Kim, HR, Kim, YS, Kim, DJ, Cho, BJ, Yang, HK, Hwang, YI, Kim, KJ, Park, HS, Hwang, DH, Cho, DH & Lee, WJ 2009, 'Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44', Carcinogenesis, vol. 30, no. 12, pp. 1987-1996. https://doi.org/10.1093/carcin/bgp158
Kang, Jae Seung ; Bae, Seyeon Y. ; Kim, Hangrae R. ; Kim, Yeong Seok ; Kim, Daejin J. ; Cho, Byung Joo ; Yang, Han Kwang ; Hwang, Young Il ; Kim, Kyungjae J. ; Park, Hong Suk ; Hwang, Doukho H. ; Cho, Dae Ho ; Lee, Wang Jae. / Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. In: Carcinogenesis. 2009 ; Vol. 30, No. 12. pp. 1987-1996.
@article{12868982197a4ec788d5c1888cfdf443,
title = "Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44",
abstract = "Cancer cells metastasize to the other site after escaping from the immune system and CD70, CD44 and vascular endothelial growth factor (VEGF) play important roles in this process. It is recently reported that interleukin (IL)-18 is closely related with the pathogenesis of skin tumor. Therefore, we investigated the role of endogenous IL-18 from stomach cancer on the immune escape mechanism and metastasis via the regulation of CD70, CD44 and VEGF expression. IL-18 and IL-18R expressions were not only investigated on tumor tissues (n = 10), and sera (n = 20) from stomach cancer patients, but also on human stomach cancer cell lines. IL-18 and IL-18R expressions were found on stomach cancer cell lines and tumor tissues. In addition, IL-18 levels were elevated in sera from cancer patients (P < 0.05), compared with sera from normal individuals. Changes in CD70, CD44 and VEGF expression by flow cytometry, immunoblotting and enzyme-linked immunosorbent assay and immune susceptibility by . 51 Cr-release assay were investigated, after silencing or neutralization of endogenous IL-18. CD70 expression was increased and it increases immune susceptibility of cancer cells. In contrast, CD44 and VEGF expression was decreased and it suppresses neovascularization and the metastasis of stomach cancer. After inoculation of IL-18 small interfering RNA (siRNA)-transfected stomach cancer cells into Balb/C (nu/nu) mice, regression of tumor mass was determined by measuring of tumor size. And the number and location of metastatic lesions were investigated by hematoxylin and eosin staining. The regression of tumor mass and the suppression of metastasis were observed in the mice, which are injected with IL-18 siRNA-transfected cell lines. Our data suggest that endogenous IL-18 might facilitate stomach cancer cell immune escape by suppressing CD70 and increasing metastatic ability by upregulating CD44 and VEGF.",
author = "Kang, {Jae Seung} and Bae, {Seyeon Y.} and Kim, {Hangrae R.} and Kim, {Yeong Seok} and Kim, {Daejin J.} and Cho, {Byung Joo} and Yang, {Han Kwang} and Hwang, {Young Il} and Kim, {Kyungjae J.} and Park, {Hong Suk} and Hwang, {Doukho H.} and Cho, {Dae Ho} and Lee, {Wang Jae}",
year = "2009",
month = "7",
day = "28",
doi = "10.1093/carcin/bgp158",
language = "English",
volume = "30",
pages = "1987--1996",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44

AU - Kang, Jae Seung

AU - Bae, Seyeon Y.

AU - Kim, Hangrae R.

AU - Kim, Yeong Seok

AU - Kim, Daejin J.

AU - Cho, Byung Joo

AU - Yang, Han Kwang

AU - Hwang, Young Il

AU - Kim, Kyungjae J.

AU - Park, Hong Suk

AU - Hwang, Doukho H.

AU - Cho, Dae Ho

AU - Lee, Wang Jae

PY - 2009/7/28

Y1 - 2009/7/28

N2 - Cancer cells metastasize to the other site after escaping from the immune system and CD70, CD44 and vascular endothelial growth factor (VEGF) play important roles in this process. It is recently reported that interleukin (IL)-18 is closely related with the pathogenesis of skin tumor. Therefore, we investigated the role of endogenous IL-18 from stomach cancer on the immune escape mechanism and metastasis via the regulation of CD70, CD44 and VEGF expression. IL-18 and IL-18R expressions were not only investigated on tumor tissues (n = 10), and sera (n = 20) from stomach cancer patients, but also on human stomach cancer cell lines. IL-18 and IL-18R expressions were found on stomach cancer cell lines and tumor tissues. In addition, IL-18 levels were elevated in sera from cancer patients (P < 0.05), compared with sera from normal individuals. Changes in CD70, CD44 and VEGF expression by flow cytometry, immunoblotting and enzyme-linked immunosorbent assay and immune susceptibility by . 51 Cr-release assay were investigated, after silencing or neutralization of endogenous IL-18. CD70 expression was increased and it increases immune susceptibility of cancer cells. In contrast, CD44 and VEGF expression was decreased and it suppresses neovascularization and the metastasis of stomach cancer. After inoculation of IL-18 small interfering RNA (siRNA)-transfected stomach cancer cells into Balb/C (nu/nu) mice, regression of tumor mass was determined by measuring of tumor size. And the number and location of metastatic lesions were investigated by hematoxylin and eosin staining. The regression of tumor mass and the suppression of metastasis were observed in the mice, which are injected with IL-18 siRNA-transfected cell lines. Our data suggest that endogenous IL-18 might facilitate stomach cancer cell immune escape by suppressing CD70 and increasing metastatic ability by upregulating CD44 and VEGF.

AB - Cancer cells metastasize to the other site after escaping from the immune system and CD70, CD44 and vascular endothelial growth factor (VEGF) play important roles in this process. It is recently reported that interleukin (IL)-18 is closely related with the pathogenesis of skin tumor. Therefore, we investigated the role of endogenous IL-18 from stomach cancer on the immune escape mechanism and metastasis via the regulation of CD70, CD44 and VEGF expression. IL-18 and IL-18R expressions were not only investigated on tumor tissues (n = 10), and sera (n = 20) from stomach cancer patients, but also on human stomach cancer cell lines. IL-18 and IL-18R expressions were found on stomach cancer cell lines and tumor tissues. In addition, IL-18 levels were elevated in sera from cancer patients (P < 0.05), compared with sera from normal individuals. Changes in CD70, CD44 and VEGF expression by flow cytometry, immunoblotting and enzyme-linked immunosorbent assay and immune susceptibility by . 51 Cr-release assay were investigated, after silencing or neutralization of endogenous IL-18. CD70 expression was increased and it increases immune susceptibility of cancer cells. In contrast, CD44 and VEGF expression was decreased and it suppresses neovascularization and the metastasis of stomach cancer. After inoculation of IL-18 small interfering RNA (siRNA)-transfected stomach cancer cells into Balb/C (nu/nu) mice, regression of tumor mass was determined by measuring of tumor size. And the number and location of metastatic lesions were investigated by hematoxylin and eosin staining. The regression of tumor mass and the suppression of metastasis were observed in the mice, which are injected with IL-18 siRNA-transfected cell lines. Our data suggest that endogenous IL-18 might facilitate stomach cancer cell immune escape by suppressing CD70 and increasing metastatic ability by upregulating CD44 and VEGF.

UR - http://www.scopus.com/inward/record.url?scp=73949144525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949144525&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgp158

DO - 10.1093/carcin/bgp158

M3 - Article

C2 - 19638429

AN - SCOPUS:73949144525

VL - 30

SP - 1987

EP - 1996

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 12

ER -